Literature DB >> 9300669

Gene delivery to the epidermis.

A H Trainer1, M Y Alexander.   

Abstract

Epidermal gene delivery techniques are being developed as an experimental approach to understanding the pathogenesis of skin disorders and for developing therapeutic strategies for the treatment of disease. This technology is being evaluated in many clinical trials in the treatment of disorders such as cutaneous melanoma and skin wounding, with 20% of all gene therapy protocols being applied in the field of dermatology. This review focuses on recent advances in the development of gene transfer technology to the epidermis, describing the diseases that may be amenable to treatment by use of these strategies. We will discuss the advantages and limitations of the currently used techniques and the future prospects for gene therapy via the epidermis.

Entities:  

Mesh:

Year:  1997        PMID: 9300669     DOI: 10.1093/hmg/6.10.1761

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  4 in total

1.  Adenoviral gene delivery to primary human cutaneous cells and burn wounds.

Authors:  Tobias Hirsch; Sebastian von Peter; Grzegorz Dubin; Dominik Mittler; Frank Jacobsen; Markus Lehnhardt; Elof Eriksson; Hans-Ulrich Steinau; Lars Steinstraesser
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

2.  Thermal Assisted In Vivo Gene Electrotransfer.

Authors:  Amy Donate; Anna Bulysheva; Chelsea Edelblute; Derrick Jung; Mohammad A Malik; Siqi Guo; Niculina Burcus; Karl Schoenbach; Richard Heller
Journal:  Curr Gene Ther       Date:  2016       Impact factor: 4.391

Review 3.  The hairless mouse in skin research.

Authors:  Fernando Benavides; Tatiana M Oberyszyn; Anne M VanBuskirk; Vivienne E Reeve; Donna F Kusewitt
Journal:  J Dermatol Sci       Date:  2008-10-19       Impact factor: 4.563

4.  Topical gene electrotransfer to the epidermis of hairless guinea pig by non-invasive multielectrode array.

Authors:  Siqi Guo; Annelise L Israel; Gaurav Basu; Amy Donate; Richard Heller
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.